Effect of Antenatal Mental Health Disorder on Fetal Growth: A Systematic Review

Rina Tri Handayani, Aris Widiyanto, Joko Tri Atmojo, Catur Setyorini


Background: Maternal mental disorders during pregnancy are associated with a range of adverse health outcomes for infants. Re­cent studies indi­cate the possible mechanism of maternal mental health disorders asso­ciated with fetal develop­ment through prog­ram­­ming effect. This study aimed to sys­tema­t­ically review the effect of ante­natal mental health disorders on fetal growth.

Subjects and Method: This was a sys­tem­atic review. The articles were selected from Psyc­INFO, Medline, Web of Science, Em­­­base, and PubMed journal databases pu­blis­hed from July to Septem­ber 2018. The keywords for this review included maternal mental health AND fetal growth, post­partum de­p­ress­­ion AND fetal growth, maternal mental health AND fetal growth AND review. As many as 11 articles were selected for this stu­dy from 575 articles.

Results: Maternal mental health during preg­nancy was associated with fetal head cir­cum­­ference growth through 2 mechanism: (1) In­creased maternal stress response modifies neu­ro­en­docrine function, which included changes in cortisol regulation, adreno­corti­co­tropic, adrena­line and nor­adrenaline hor­mo­nes levels; and (2) Decreased 11β-hydroxy­steroid dehydrogenase (11β-HSD2) enzyme regulation in placenta. It decreased11β-HSD2 level, increa­s­ed fetal gluco­corticoids circu­la­tion, and affect­ed on fetal head growth restriction.

Conclusion: Maternal mental health during pregnancy is associated with fetal head circ­um­­fe­rence growth restriction.

Keywords: maternal mental health, fetal head circumference, growth, systematic re­view

Correspondence: Rina Tri Handayani. School of Health Scien­ces Mamba'ul 'Ulum, Surakarta, Jl. Ring Road Utara, Tawangsari, Mojosongo, Jebres, Sura­­ka­r­ta, Cen­tral Java. Email: trihandayan­ir­ina­@gmail­.­com: 085642224141

Journal of Maternal and Child Health (2020), 5(2): 147-153

Full Text:



Achard V, Boullu C S, Desbriére R, Grino M(2006). Perinatal programming of central obesity and the metabolic syndrome: Role of glucocorticoids. Metabolic Syndrome and Related Disorders. 4(2):129-37. doi: 10.1089/met.2006.4.129 [Crossref] [PubMed] [Google Scholar]

American Psychiatric Association (2013) Diagnostic statistical manual of mental disorders. American Journal of Psychiatry.

Baschat AA (2011). Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction. Ultrasound in Obstetrics and Gynecology. 37(5):501-14. doi: 10.1002/uog.9008 [Crossref] [PubMed] [Google Scholar]

Bennett H, Einarson A, Taddio A, Koren G, Einarson TR (2004). Prevalence of depression during pregnancy: Systematic review. Obstetrics and Gynecology. 103(4):698-709. doi: 10.1097/01.aog.0000116689.75396.5f [Crossref] [PubMed] [Google Scholar]

Das UG, Sysyn GD (2004). Abnormal fetal growth: Intrauterine growth retardation, small for gestational age, large for gestational age. Pediatric Clinics of North America. 51(3): 639-54. doi: 10.1016/j.pcl.2004.01.004 [Crossref] [PubMed] [Google Scholar]

Diego MA, Jones NA, Field T, Hernandez RM, Schanberg S, Kuhn C, Gonzalez GA (2006). Maternal psychological distress, prenatal cortisol, and fetal weight. Psychosomatic Medicine. 68(5): 747-53. doi: 10.1097/01.psy.0000238212.21598.7b [Crossref] [PubMed] [Google Scholar]

Gaynes BN, Gavin N, Meltzer-Brody S, Lohr KN, Swinson T, Gartlehner G, Brody S, Miller WC (2005). Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evidence report/technology assessment (Summary). (119): 1-8. [PubMed] [Google Scholar]

Howard LM, Molyneaux E, Dennis CL, Rochat T, Stein A, Milgrom J (2014). Non-psychotic mental disorders in the perinatal period. The Lancet. 384(9956):1775-88. doi: 10.1016/s0140-6736(14)61276-9 [Crossref] [Google Scholar]

Lee AM, Lam SK, Sze ML, Stephanie MC, Catherine SY, Chui HW, Fong DYT (2007). Prevalence, course, and risk factors for antenatal anxiety and depression. Obstetrics and Gynecology. 110(5): 1102-12. doi: 10.1097/01.aog.0000287065.59491.70 [Crossref] [PubMed] [Google Scholar]

Lewis A, Austin E, Knapp R, Vaiano T, Galbally M (2015). Perinatal Maternal Mental Health, Fetal Programming and Child Development. Healthcare, 3(4): 1212–1227. doi: 10.3390/healthcare3041212 [Crossref] [PubMed] [Google Scholar]

Lewis AJ, Austin E, Galbally M (2016). Prenatal maternal mental health and fetal growth restriction: a systematic review. Journal of Developmental Origins of Health and Disease, 7(04): 416–428. doi: 10.1017/s2040174416000076 [Crossref] [PubMed] [Google Scholar]

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, Clarke M (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ.

(1): b2700–b2700. doi: 10.1136/bmj.b2700 [Crossref] [PubMed] [Google Scholar]

NiL, Pan, Yibin T, Chao X, Wenyi W, Ximei Z, Chaochun (2018). Antenatal exposure to betamethasone induces placental 11β-hydroxysteroid dehydro-genase type 2 expression and the adult metabolic disorders in mice. PLoS ONE, 13(9): 1–15. doi: 10.1371/journal.pone.0203802 [Crossref] [PubMed] [Google Scholar]

Quinkler M, Oelkers W, Diederich S (2001). Clinical implications of glucocorticoid metabolism by 11β-hydroxysteroid dehydrogenases in target tissues. European Journal of Endocrinology. 144(2): 87-97. doi: 10.1530/eje.0.1440087 [Crossref] [PubMed] [Google Scholar]

Seth S, Lewis AJ, Saffery R, Lappas M, Galbally M (2015). Maternal prenatal mental health and placental 11β-HSD2 gene expression: Initial findings from the mercy pregnancy and emotionalwellbeing study. International Journal of Molecular Sciences. 16(11):27482-96. doi: 10.3390/ijms161126034 [Crossref] [PubMed] [Google Scholar]

Seckl JR, Holmes MC (2007). Mechanisms of disease: Glucocorticoids, their placental metabolism and fetal”programming”of adult pathophysiology. Nature Clinical Practice Endocrinology and Metabolism. 3(6):479-88. doi: 10.1038/ncpendmet0515 [Crossref] [PubMed] [Google Scholar]

Seng JS, Rauch SAM, Resnick H, Reed CD, King AL, Lisa K, McPherson M (2010). Exploring posttraumatic stress disorder symptom profile among pregnant women. Journal of Psychosomatic Obstetrics and Gynecology. 31(3):176-87. doi: 10.3109/0167482x.2010.486453 [Crossref] [PubMed] [Google Scholar]

Thompson A, Han VKM, Yang K (2004). Differential expression of 11β-hydroxysteroid dehydrogenase types 1 and 2 mRNA and glucocorticoid receptor protein during mouse embryonic development. Journal of Steroid Biochemistry and Molecular Biology. 88(4–5): 367-375. doi: 10.1016/j.jsbmb.2003.12.014 [Crossref] [PubMed] [Google Scholar]

Wächter R, Masarik L, Bürzle M, Mallik A, Von Mandach U (2009). Differential expression and activity of 11β-hydroxysteroid dehydrogenase in human placenta and fetal membranes from pregnancies with intrauterine growth restriction. Fetal Diagnosis and Therapy. 25: 328–335. doi: 10.1016/j.jsbmb.2003.12.014 [Crossref] [PubMed] [Google Scholar]

Wu G, Imhoff-Kunsch B, Girard AW (2012). Biological mechanisms for nutritional regulation of maternal health and fetal development. Paediatric and Perinatal Epidemiology. 26(1): 4-26. doi: 10.1111/j.1365-3016.2012.01291.x [Crossref] [PubMed] [Google Scholar]


  • There are currently no refbacks.